Demser (Metyrosine) - Summary

DEMSER SUMMARY

DEMSER ^®
(METYROSINE)
CAPSULES

DEMSER (Metyrosine) inhibits tyrosine hydroxylase, which catalyzes the first transformation in catecholamine biosynthesis, i.e., the conversion of tyrosine to dihydroxyphenylalanine (DOPA).

DEMSER is indicated in the treatment of patients with pheochromocytoma for:

1. Preoperative preparation of patients for surgery
2. Management of patients when surgery is contraindicated
3. Chronic treatment of patients with malignant pheochromocytoma.

DEMSER is not recommended for the control of essential hypertension.

DEMSER NEWS HIGHLIGHTS

Published Studies Related to Demser (Metyrosine)

Metyrosine in psychosis associated with 22q11.2 deletion syndrome: case report. [2007.02]

Metyrosine and pheochromocytoma. [1997.04.28]

Surgical management of pheochromocytoma with the use of metyrosine. [1990.11]

more>>

Clinical Trials Related to Demser (Metyrosine)

Treatment of Orthostatic Hypotension [Recruiting]

PET Imaging of Dopamine in Healthy Study Participants [Completed]

131MIBG to Treat Malignant Pheochromocytoma [Recruiting]

more>>